THE EFFECTS OF ORAL STANOZOLOL ON FIBRINOLYSIS IN TYPE-2 DIABETES-MELLITUS

被引：4

作者：

SMALL, M ^{[1
]}

LOWE, GDO ^{[1
]}

MACCUISH, AC ^{[1
]}

FORBES, CD ^{[1
]}

机构：

[1] UNIV GLASGOW, ROYAL INFIRM, DEPT MED, GLASGOW G4 0SF, SCOTLAND

来源：

THROMBOSIS RESEARCH | 1986年 / 44卷 / 02期

关键词：

D O I：

10.1016/0049-3848(86)90142-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：253 / 259

页数：7

共 27 条

[1] DIABETIC-RETINOPATHY AND FIBRINOLYTIC SYSTEM [J].

ALMER, LO ;

PANDOLFI, M ;

NILSSON, IM .

DIABETES, 1975, 24 (06) :529-534

[2] TREATMENT OF LIPOSCLEROSIS OF LEG BY FIBRINOLYTIC ENHANCEMENT - PRELIMINARY-REPORT [J].

BROWSE, NL ;

JARRETT, PEM ;

MORLAND, M ;

BURNAND, K .

BMJ-BRITISH MEDICAL JOURNAL, 1977, 2 (6084) :434-435

[3] VENOUS LIPODERMATOSCLEROSIS - TREATMENT BY FIBRINOLYTIC ENHANCEMENT AND ELASTIC COMPRESSION [J].

BURNAND, K ;

CLEMENSON, G ;

MORLAND, M ;

JARRETT, PEM ;

BROWSE, NL .

BMJ-BRITISH MEDICAL JOURNAL, 1980, 280 (6206) :7-11

[4] PHARMACOLOGICAL FIBRINOLYSIS IN DIABETES-MELLITUS [J].

CHAKRABARTI, R ;

FEARNLEY, GR .

DIABETOLOGIA, 1974, 10 (01) :19-22

[5]

CHRISTE M, 1984, THROMB HAEMOSTASIS, V52, P138

[6] NEW CONCEPTS ABOUT THE PATHOGENESIS OF ATHEROSCLEROSIS IN DIABETES-MELLITUS [J].

COLWELL, JA ;

WINOCOUR, PD ;

LOPESVIRELLA, M ;

HALUSHKA, PV .

AMERICAN JOURNAL OF MEDICINE, 1983, 75 (5B) :67-80

[7]

CUNLIFFE WJ, 1975, PROGR CHEMICAL FIBRI, V1, P325

[8] FIBRINOLYTIC ENHANCEMENT BY STANOZOLOL - DOUBLE-BLIND TRIAL [J].

DAVIDSON, JF ;

LOCHHEAD, M ;

MCDONALD, GA ;

MCNICOL, GP .

BRITISH JOURNAL OF HAEMATOLOGY, 1972, 22 (05) :543-+

[9] PLASMA HEMOSTATIC FACTORS AND DIABETIC-RETINOPATHY [J].

DORNAN, TL ;

RHYMES, IL ;

CEDERHOLMWILLIAMS, SA ;

RIZZA, CR ;

PEPYS, MB ;

BRON, AJ ;

TURNER, RC .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1983, 13 (03) :231-235

[10]

DOUGLAS JT, 1985, THROMB HAEMOSTASIS, V53, P235

← 1 2 3 →